bovnews29m
H.C. Wainwright Just Reiterated BigBear.ai Holdings Inc (BBAI) Stock—What Does This Mean for Investors?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 28.87% ...
bovnews3h
Why Did H.C. Wainwright Give Microbot Medical Inc (MBOT) Stock Buy Rating?
H.C. Wainwright has recently reiterated Microbot Medical Inc (MBOT) stock to Buy rating, as announced on January 13, 2020, according to Finviz. Earlier, on December 24, 2019, H.C. Wainwright had ...
H.C. Wainwright maintains $190 target on Cybin Inc. shares
H.C. Wainwright reaffirmed its Buy rating on Cybin Inc. (NYSE:CYBN) with a steady price target of $190.00, significantly above the current trading price of $9.59. With a market capitalization of $192 ...
Transcat’s Strategic Acquisitions and Growth Potential Justify Buy Rating Despite Current Challenges
H.C. Wainwright analyst Scott Buck maintained a Buy rating on Transcat (TRNS – Research Report) today and set a price target of $126.00.Invest ...
Strong Outlook for Cartesian Therapeutics: FDA SPA Agreement and Positive Phase 2b Results Boost Confidence in Descartes-08
Mitchell Kapoor, an analyst from H.C. Wainwright, reiterated the Buy rating on Cartesian Therapeutics (RNAC – Research Report). The associated ...
Personalis (NASDAQ:PSNL) Price Target Lowered to $8.00 at HC Wainwright
Personalis (NASDAQ:PSNL – Free Report) had its price objective decreased by HC Wainwright from $11.00 to $8.00 in a research report sent to investors on Monday morning,Benzinga reports. HC Wainwright ...
Analysts Offer Predictions for Genmab A/S FY2024 Earnings
Investment analysts at HC Wainwright issued their FY2024 earnings per share estimates for Genmab A/S in a report issued on ...